Palliative surgical treatment of patients, suffering proximal tumoral affection of biliary ducts and the jaundice syndrome

Keywords: obturation jaundice; Klatskin tumor; external-internal suprapapillary cholangiostomy; transcutaneous transhepatic antegrade endobiliary stenting; endoscopic retrograde biliary stenting; cholangitis; life span.

Abstract

Objective. To compare the efficacy of methods of miniinvasive palliative treatment of malignant hilar strictures with the jaundice syndrome.

Materials and methods. Into the investigation 71 patients, suffering proximal obturation jaundice of tumoral genesis, were included. The patients were divided into three Groups: Group I - 26 patients, to whom external-internal suprapapillary cholangiostomy was done; Group II - 28 patients, in whom transcutaneous transhepatic antegrade endobiliary stenting was performed; Group III -17 patients, to whom endoscopic retrograde biliary stenting was accomplished.

Results. Technical success in all the Groups have constituted 100%; clinical one - in 94.0%: in Group I - 96.2%, in Group II - 89.3%, and in group III - 82.4% (p>0.05). In Group I general rate of morbidity was lesser, including cholangitis and pancreatitis. The duration of cholangitis was lesser as well. Cumulative survival were the highest in Group of patients, to whom external-internal suprapapillary cholangiostomy was performed (135 days at average), while the least one - in Group of the patients, in whom endoscopic retrograde biliary stenting was done (90,6 days). In Group of patients, to whom transcutaneous transhepatic antegrade endobiliary stenting was performed, this index have constitited 101.2 days.

Conclusion. In proximal strictures of biliary ducts of tumoral genesis on background of jaundice the priority method of palliative treatment must be external-internal suprapapillary cholangiostomy, while the second-line of surgical treatment must constitute transcutaneous transhepatic antegrade endobiliary stenting. Endoscopic retrograde biliary stenting owes the lowest priority.

Author Biographies

Ya. M. Susak, Bogomolets National Medical University, Kyiv

Susak Yaroslav Mikhaylovich, MD, DSci(Med), professor
Department of surgery with emergency and vascular surgery,
Bogomolets National Medical University,
13 T. Shevchenko blvd, Kyiv, 01601, Ukraine;
+38 (044) 234-92-76;
+38 (067) 233 39 65
yarsus@ukr.net
http://orcid.org/0000-0002-5102-485X

R. Ya. Palytsya, National Military Medical Clinical Centre «The Main Military Clinical Hospital», Kyiv

Palytsya Roman Yaroslavovich, MD, surgeon
Main military clinical hospital,
Hospitalnay Str., Kyiv, 01601,
+38 (097)788 83 72
roma.palytsya@gmail.com
https://orcid.org/0000-0001-8897-5336

L. Yu. Markulan, Bogomolets National Medical University, Kyiv

Markulan Leonid Yuriyovych, MD, PhD, associate professor
Department of surgery with emergency and vascular surgery,
Bogomolets National Medical University, Kyiv,
13 T. Shevchenko blvd, Kyiv, 01601, Ukraine;
+38 (044) 234-92-76
markulan@ukr.net; phone:
+38 (067) 745 00 14
https://orcid.org/0000-0003-2879-5012

O. O. Dyrda, Kyiv’s Municipal Clinical Hospital of Emergent Help

Dyrda Oleksandr Olegovich, MD, PhD, surgeon
Kyiv City Clinical Emergency Hospital,
Bratislavskay str. 3, Kyiv, 02136, Ukraine,
+38 (097)740 8533
dirda.m.d@gmail.com
https://orcid.org/0000-0002-0736-5905

References

Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013 Dec;145(6):1215-29. doi: 10.1053/j.gastro.2013.10.013. Epub 2013 Oct 15. PMID: 24140396; PMCID: PMC3862291.

Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016 May;13(5):261-80. doi: 10.1038/nrgastro.2016.51. Epub 2016 Apr 20. PMID: 27095655.

Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-88. doi: 10.1038/s41575-020-0310-z. Epub 2020 Jun 30. PMID: 32606456; PMCID: PMC7447603.

Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004 May;24(2):115-25. doi: 10.1055/s-2004-828889. PMID: 15192785.

Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. Gastroenterology. 2009 Apr;136(4):1134-44. doi: 10.1053/j.gastro.2009.02.038. Epub 2009 Feb 24. PMID: 19245868.

Bertuccio P, Malvezzi M, Carioli G, Hashim D, Boffetta P, El-Serag HB, et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol. 2019 Jul;71(1):104-14. doi: 10.1016/j.jhep.2019.03.013. Epub 2019 Mar 23. PMID: 30910538.

Yao KJ, Jabbour S, Parekh N, Lin Y, Moss RA. Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database. BMC Gastroenterol. 2016 Sep 21;16(1):117. doi: 10.1186/s12876-016-0527-z. PMID: 27655244; PMCID: PMC5031355.

Sahinli H, Özet A. Prognostic and predictive factors in cancer patients with obstructive jaundice treated by percutaneous transhepatic biliary drainage: A single-center experience. J Cancer Res Ther. 2020 Dec;16(Supplement):S99-S103. doi: 10.4103/jcrt.JCRT_521_19. PMID: 33380661.

van Vugt JLA, Gaspersz MP, Coelen RJS, Vugts J, Labeur TA, de Jonge J, et al. The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma. HPB (Oxford). 2018 Jan;20(1):83-92. doi: 10.1016/j.hpb.2017.08.025. Epub 2017 Sep 25. PMID: 28958483.

Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013 Jul;258(1):129-40. doi: 10.1097/SLA.0b013e3182708b57. PMID: 23059502.

Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014 Feb;3(1):18-34. doi: 10.3978/j.issn.2304-3881.2014.02.05. PMID: 24696835; PMCID: PMC3955000.

Fong ZV, Brownlee SA, Qadan M, Tanabe KK. The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines. Ann Surg Oncol. 2021 Mar 1. doi: 10.1245/s10434-021-09671-y. Epub ahead of print. PMID: 33646431.

Paik WH, Park YS, Hwang JH, Lee SH, Yoon CJ, Kang SG, et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc. 2009 Jan;69(1):55-62. doi: 10.1016/j.gie.2008.04.005. Epub 2008 Jul 26. PMID: 18657806.

Mayhew D, Mendonca V, Murthy BVS. A review of ASA physical status - historical perspectives and modern developments. Anaesthesia. 2019 Mar;74(3):373-9. doi: 10.1111/anae.14569. Epub 2019 Jan 15. PMID: 30648259.

Inal M, Akgül E, Aksungur E, Demiryürek H, Yağmur O. Percutaneous self-expandable uncovered metallic stents in malignant biliary obstruction. Complications, follow-up and reintervention in 154 patients. Acta Radiol. 2003 Mar;44(2):139-46. doi: 10.1034/j.1600-0455.2003.00049.x. PMID: 12694096.

Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003 Sep;14(9 Pt 2):S199-202. doi: 10.1097/01.rvi.0000094584.83406.3e. PMID: 14514818.

Pranculis A, Kievišas M, Kievišienė L, Vaičius A, Vanagas T, Kaupas RS, et al. Percutaneous Transhepatic Biliary Stenting with Uncovered Self-Expandable Metallic Stents in Patients with Malignant Biliary Obstruction - Efficacy and Survival Analysis. Pol J Radiol. 2017 Aug 10;82:431-40. doi: 10.12659/PJR.901785. PMID: 29662569; PMCID: PMC5894070.

Telford JJ, Carr-Locke DL, Baron TH, Poneros JM, Bounds BC, Kelsey PB, et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc. 2010 Nov;72(5):907-14. doi: 10.1016/j.gie.2010.08.021. PMID: 21034891.

Yu H, Yuanyuan S, Guo Z, Xing W, Si T, Guo X, et al. Multifactorial analysis of biliary infection after percutaneous transhepatic biliary drainage treatment of malignant biliary obstruction. J Cancer Res Ther. 2018;14(7):1503-8. doi: 10.4103/jcrt.JCRT_256_18. PMID: 30589030.

Mine T, Morizane T, Kawaguchi Y, Akashi R, Hanada K, Ito T, et al. Clinical practice guideline for post-ERCP pancreatitis. J Gastroenterol. 2017 Sep;52(9):1013-22. doi: 10.1007/s00535-017-1359-5. Epub 2017 Jun 26. PMID: 28653082.

Riaz A, Pinkard JP, Salem R, Lewandowski RJ. Percutaneous management of malignant biliary disease. J Surg Oncol. 2019 Jul;120(1):45-56. doi: 10.1002/jso.25471. Epub 2019 Apr 12. PMID: 30977913.

van Delden OM, Laméris JS. Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol. 2008 Mar;18(3):448-56. doi: 10.1007/s00330-007-0796-6. Epub 2007 Oct 25. PMID: 17960388.

Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975 Feb;140(2):170-8. PMID: 1079096.

Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, Khor CJ, Ponnudurai R, Moon JH, et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2013 Apr;28(4):593-607. doi: 10.1111/jgh.12128. PMID: 23350673.

Lee TH, Moon JH, Park SH. Biliary stenting for hilar malignant biliary obstruction. Dig Endosc. 2020 Jan;32(2):275-86. doi: 10.1111/den.13549. Epub 2019 Dec 18. PMID: 31578770.

De Palma GD, Galloro G, Siciliano S, Iovino P, Catanzano C. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc. 2001 May;53(6):547-53. doi: 10.1067/mge.2001.113381. PMID: 11323577.

Iwano H, Ryozawa S, Ishigaki N, Taba K, Senyo M, Yoshida K, et al. Unilateral versus bilateral drainage using self-expandable metallic stent for unresectable hilar biliary obstruction. Dig Endosc. 2011 Jan;23(1):43-8. doi: 10.1111/j.1443-1661.2010.01036.x. Epub 2010 Nov 30. PMID: 21198916.

Dowsett JF, Vaira D, Hatfield AR, Cairns SR, Polydorou A, Frost R, et al. Endoscopic biliary therapy using the combined percutaneous and endoscopic technique. Gastroenterology. 1989 Apr;96(4):1180-6. doi: 10.1016/0016-5085(89)91639-9. PMID: 2925062.

Son RC, Gwon DI, Ko HK, Kim JW, Ko GY. Percutaneous unilateral biliary metallic stent placement in patients with malignant obstruction of the biliary hila and contralateral portal vein steno-occlusion. Korean J Radiol. 2015 May-Jun;16(3):586-92. doi: 10.3348/kjr.2015.16.3.586. Epub 2015 May 13. PMID: 25995688; PMCID: PMC4435989.

Jang SI, Hwet al Lee YS, Paik KH, Lee SH, Lee DK. Percutaneous biliary approach as a successful rescue procedure after failed endoscopic therapy for drainage in advanced hilar tumors. J Gastroenterol Hepatol. 2017 Apr;32(4):932-8. doi: 10.1111/jgh.13602. PMID: 27665310.

Moole H, Bechtold ML, Forcione D, Puli SR. A meta-analysis and systematic review: Success of endoscopic ultrasound guided biliary stenting in patients with inoperable malignant biliary strictures and a failed ERCP. Medicine (Baltimore). 2017 Jan;96(3):e5154. doi: 10.1097/MD.0000000000005154. PMID: 28099327; PMCID: PMC5279072.

Wang L, Lin N, Xin F, Ke Q, Zeng Y, Liu J. A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction. World J Surg Oncol. 2019 Jul 5;17(1):116. doi: 10.1186/s12957-019-1656-y. PMID: 31277666; PMCID: PMC6612106.

Pedersen FM, Lassen AT, Schaffalitzky de Muckadell OB. Randomized trial of stent placed above and across the sphincter of Oddi in malignant bile duct obstruction. Gastrointest Endosc. 1998 Dec;48(6):574-9. doi: 10.1016/s0016-5107(98)70038-0. PMID: 9852446.

Scheufele F, Aichinger L, Jäger C, Demir IE, Schorn S, Sargut M, et al. Effect of preoperative biliary drainage on bacterial flora in bile of patients with periampullary cancer. Br J Surg. 2017 Jan;104(2):e182-e188. doi: 10.1002/bjs.10450. PMID: 28121036.

Chandrashekhara SH, Gamanagatti S, Singh A, Bhatnagar S. Current Status of Percutaneous Transhepatic Biliary Drainage in Palliation of Malignant Obstructive Jaundice: A Review. Indian J Palliat Care. 2016 Oct-Dec;22(4):378-87. doi: 10.4103/0973-1075.191746. PMID: 27803558; PMCID: PMC5072228.

Published
2020-12-28
How to Cite
Susak, Y. M., Palytsya, R. Y., Markulan, L. Y., & Dyrda, O. O. (2020). Palliative surgical treatment of patients, suffering proximal tumoral affection of biliary ducts and the jaundice syndrome. Klinicheskaia Khirurgiia, 87(11-12), 40-47. https://doi.org/10.26779/2522-1396.2020.11-12.40
Section
General Problems of Surgery

Most read articles by the same author(s)